Generated Narrative: RegulatedAuthorization MA-68291002 Profile: RegulatedAuthorization identifier: Marketing Authorisation Number/68291002 subject: PackagedProductDefinition: identifier = http://fhir.ch/ig/ch-idmp/sid/pcid#Clinical Product Identifier#CH-01100869-0682910030000-0001; containedItemQuantity = 20 mg; description = Durchstechflasche 1 Stk type: Marketing Authorisation region: Switzerland status: approved statusDate: 2021-11-09 validityPeriod: 2021-11-09 --> 2026-11-08 holder: Organization Astellas Pharma AG regulator: Organization SMC Generated Narrative: Organization #holder-Astellas-Pharma-AG Profile: Organization identifier: Swissmedic Location Identifier/01100869, LOC Identifier/100010745, GLN Identifier/7601001000964 name: Astellas Pharma AG Generated Narrative: Organization #regulator-SMC Profile: Organization identifier: LOC Identifier/100010911, GLN Identifier/7601001398511 name: SMC